Tafenoquine and Beyond: CEO's Vision for the Future of 60 Degrees Pharmaceuticals
2 years ago
1
Learn about Sixty Degrees Pharma (Nasdaq: SXTP) from CEO Geoff Dow. In this exclusive overview, Dow provides insight into the company's mission to develop and commercialize new therapies for a range of infectious diseases, including its FDA-approved malaria preventative treatment ARAKODA® and the Company's current pipeline development programs for Tafenoquine and Celgosivir targeting COVID-19, fungal, tick-borne, and other viral diseases. Learn more about this game-changing small-cap stock by visiting SXTPinfo.com today.
Loading comments...
-
LIVE
Wendy Bell Radio
5 hours agoDemocrats Go Down In Flames
9,636 watching -
LIVE
Randi Hipper
25 minutes agoTRUMP MEDIA BUYS $2 BIILLION OF BITCOIN AS PRICE NEARS ALL TIME HIGH
104 watching -
LIVE
Matt Kohrs
9 hours agoMarket Open: LIVE! Trading $1M & Breaking Stock News
1,044 watching -
25:51
Clownfish TV
5 hours agoColbert Lost CBS $40 to $50 MILLION Per Year?!
4392 -
LIVE
The Mike Schwartz Show
54 minutes agoTHE MIKE SCHWARTZ SHOW with DR. MICHAEL J SCHWARTZ 07-22-2025
4,224 watching -
LIVE
LFA TV
12 hours agoLFA TV ALL DAY STREAM - TUESDAY 7/22/25
3,075 watching -
1:21:54
JULIE GREEN MINISTRIES
3 hours agoEXPOSING AND BRINGING DOWN WHO REALLY CONTROLS THE ESTABLISHMENT IN DC
99.4K126 -
1:34:27
Chicks On The Right
4 hours agoHunter Biden is probably running for office, the Fireaid scam, and we need to talk about J Lo.
21.3K7 -
1:59:40
AP4Liberty
11 hours ago $0.62 earnedOrgan Harvest Horror: When Bureaucracy Trumps Biology
8.53K -
1:22:08
Game On!
17 hours ago $3.04 earnedDonald Trump DEMANDS Washington Football Team Change Their Name Back To Redskins!
37.5K2